Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis B Rice

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|September 26, 2022
Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an <i>In Vitro</i> Pharmacodynamic Model Using Humanized Dosing SimulationsJaclyn A Cusumano, Kathryn E Daffinee, Emily C Piehl, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamasesDavid L Paterson, Kristine M Hujer, Andrea M Hujer, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistinAndrea Endimiani, Gopi Patel, Kristine M Hujer, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2015
Mutation landscape of acquired cross-resistance to glycopeptide and β-lactam antibiotics in Enterococcus faeciumEmmanuelle Sacco, Mélanie Cortes, Nathalie Josseaume, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2014
Peptidoglycan cross-linking in glycopeptide-resistant ActinomycetalesJean-Emmanuel Hugonnet, Nabila Haddache, Carole Veckerlé, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 14, 2003
A clinical strain of Escherichia coli possessing CMY-2 plasmid-mediated amp C beta-lactamase: an emerging concern in pediatrics?Claudia M Hoyen, Andrea M Hujer, Kristine M Hujer, et al.
The Journal of Biological Chemistry|September 8, 2005
A novel peptidoglycan cross-linking enzyme for a beta-lactam-resistant transpeptidation pathwayJean-Luc Mainardi, Martine Fourgeaud, Jean-Emmanuel Hugonnet, et al.
BMC Microbiology|January 27, 2011
The hylEfm gene in pHylEfm of Enterococcus faecium is not required in pathogenesis of murine peritonitisDiana Panesso, Maria C Montealegre, Sandra Rincón, et al.
The Journal of Biological Chemistry|May 6, 2011
Inactivation kinetics of a new target of beta-lactam antibioticsSébastien Triboulet, Michel Arthur, Jean-Luc Mainardi, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Impact of specific pbp5 mutations on expression of beta-lactam resistance in Enterococcus faeciumLouis B Rice, Samuel Bellais, Lenore L Carias, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|September 26, 2022
Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an <i>In Vitro</i> Pharmacodynamic Model Using Humanized Dosing SimulationsJaclyn A Cusumano, Kathryn E Daffinee, Emily C Piehl, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamasesDavid L Paterson, Kristine M Hujer, Andrea M Hujer, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistinAndrea Endimiani, Gopi Patel, Kristine M Hujer, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2015
Mutation landscape of acquired cross-resistance to glycopeptide and β-lactam antibiotics in Enterococcus faeciumEmmanuelle Sacco, Mélanie Cortes, Nathalie Josseaume, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2014
Peptidoglycan cross-linking in glycopeptide-resistant ActinomycetalesJean-Emmanuel Hugonnet, Nabila Haddache, Carole Veckerlé, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 14, 2003
A clinical strain of Escherichia coli possessing CMY-2 plasmid-mediated amp C beta-lactamase: an emerging concern in pediatrics?Claudia M Hoyen, Andrea M Hujer, Kristine M Hujer, et al.
The Journal of Biological Chemistry|September 8, 2005
A novel peptidoglycan cross-linking enzyme for a beta-lactam-resistant transpeptidation pathwayJean-Luc Mainardi, Martine Fourgeaud, Jean-Emmanuel Hugonnet, et al.
BMC Microbiology|January 27, 2011
The hylEfm gene in pHylEfm of Enterococcus faecium is not required in pathogenesis of murine peritonitisDiana Panesso, Maria C Montealegre, Sandra Rincón, et al.
The Journal of Biological Chemistry|May 6, 2011
Inactivation kinetics of a new target of beta-lactam antibioticsSébastien Triboulet, Michel Arthur, Jean-Luc Mainardi, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Impact of specific pbp5 mutations on expression of beta-lactam resistance in Enterococcus faeciumLouis B Rice, Samuel Bellais, Lenore L Carias, et al.
Pageof 11